Viewing Study NCT00907166


Ignite Creation Date: 2025-12-24 @ 4:44 PM
Ignite Modification Date: 2025-12-29 @ 12:25 AM
Study NCT ID: NCT00907166
Status: TERMINATED
Last Update Posted: 2017-03-21
First Post: 2009-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients
Sponsor: Cornerstone Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module